2024-09-16
1 小时 10 分钟Could psychedelics revolutionize mental health care? Psychiatrist Dr. Will Van Derveer openingly discusses his exploration of psychedelic-assisted therapies after becoming disillusioned with conventional treatments. He details remarkable results using ketamine, psilocybin, and MDMA for conditions like PTSD and depression. With the FDA's imminent decision on rescheduling MDMA, Van Derveer provides an inside look at these groundbreaking medicines' therapeutic potential. For those struggling with mental health issues, this candid conversation may reveal new hope. You can find Will at: Website | Higher Practice Podcast | Episode Transcript If you LOVED this episode you’ll also love the conversations we had with Adam Gazzaley about cutting-edge research he’s leading in this field. Check out our offerings & partners: Join My New Writing Project: Awake at the WheelVisit Our Sponsor Page For Great Resources & Discount Codes Hosted on Acast. See acast.com/privacy for more information.
I think the biggest message I can offer is a message of hope that the things that people are out there suffering with that seem so impossible to overcome.
There are new tools being developed that hopefully will become available widely.
In the case with MDMA hopefully this year, and with psilocybin next year on the federal level, it's really devastating to be dealing with a chronic illness of any kind that you, in good faith, try everything there is to try, and you still don't get much return for your investment and effort.
And I want people to know that these things are not for everybody.
They're not a panacea.
But there's an incredible opportunity here.
These tools are very powerful and they're not to be played around with lightly, but they have incredible potential.
So that's where the art of the practice comes in, is to try to discern, like, what does this person really need?
So these days, you're probably seeing more and more headlines in the media about the potential of psychedelic assisted treatments, psilocybin from magic mushrooms, MDMA and ketamine being explored as novel therapies for mental health conditions like depression, PTSD, and anxiety.
We have had a number of guests on to talk about various aspects, from the research to the underground of psychedelics.
But beyond the initial intrigue, I have become deeply curious.
How much do we really understand about what these substances truly are, how they work therapeutically and the real world impacts, concerns and applications for the future of mental health care?
Which is why I am so excited to share this frank science based and practice based conversation about this kind of nebulous world of psychedelics.
My guest today is Doctor Will Vanderveer.
Will is a psychiatrist, researcher and educator and co founder of the Integrative Psychiatry Institute, which offers comprehensive training for mental health professionals in the application of psilocybin, MDMA, and ketamine assisted psychotherapy.
In addition to his clinical work and teaching, he's also been involved in several pioneering clinical trials, including investigating MDMA assisted psychotherapy for chronic treatment resistant PTSD.
Will's also a dear friend who I found over the years to be just incredibly well educated and also frank and grounded and honest and real about this rapidly evolving and often wildly misunderstood and confusing landscape.
So I wanted to get very detailed, very granular, and drill down into the truths, the myths, the science, applications, concerns and red flags, history and the future of the three leading substances in this landscape of psychedelic assisted therapy, ketamine, psilocybin and MDMA.
So we explore the profound mental health impacts already being uncovered in the research and in practical application, the critical role of therapist guidance and integration work, as well as the personal and cultural shifts required to really embrace these powerful but highly misunderstood medicines in an intelligent and safe way.
If you or someone you care about has struggled to find real relief from depression, anxiety, trauma, or other stubborn mental health challenges, this eye opening discussion offers a refreshing lens of both truth and possibility.